about
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone lossResiniferatoxin: The Evolution of the "Molecular Scalpel" for Chronic Pain ReliefIntrathecal resiniferatoxin in a dog model: efficacy in bone cancer pain.Multifunctional materials for bone cancer treatment.The application of genomic and molecular data in the treatment of chronic cancer pain.Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-α expression in a mouse model.Cancer Pain: A Critical Review of Mechanism-based Classification and Physical Therapy Management in Palliative CareTargeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancerEnhanced excitability of small dorsal root ganglion neurons in rats with bone cancer pain.Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.Chemokines: integrators of pain and inflammation.Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.Ensuring pain relief for children at the end of life.Radiotherapy Suppresses Bone Cancer Pain through Inhibiting Activation of cAMP Signaling in Rat Dorsal Root Ganglion and Spinal Cord.Characteristics and prognostic factors for pain management in 152 patients with lung cancer.Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer painImpacts of anti-nerve growth factor antibody on pain-related behaviors and expressions of opioid receptor in spinal dorsal horn and dorsal root ganglia of rats with cancer-induced bone pain.Analgesic effects of adenylyl cyclase inhibitor NB001 on bone cancer pain in a mouse model.An overview of animal models of pain: disease models and outcome measures.Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone painA by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes.Adjuvant analgesics in cancer pain: a review.Intrasomatic injection of corticosteroid followed by vertebroplasty increases early pain relief rather than vertebroplasty alone in vertebral bone neoplasms: preliminary experience.Animal models of pain for drug discovery.Basic aspects of musculoskeletal pain: from acute to chronic pain.Spinal neuronal correlates of tapentadol analgesia in cancer pain: a back-translational approach.MRI-guided focused ultrasound robotic system for the treatment of bone cancer.Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?Pain evoked by pressure stimulation on the tibia bone - influence of probe diameter on tissue stress and strain.Resveratrol attenuates bone cancer pain through regulating the expression levels of ASIC3 and activating cell autophagy.Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord.A human experimental bone pain model.Bone hyperalgesia after mechanical impact stimulation: a human experimental pain model.Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.
P2860
Q24615787-01463A8D-58AD-4B17-A69E-01E73F69B6E5Q26741184-D850BC08-551F-441A-A3C2-DE05532502C3Q27316416-5991A1F4-1ACA-4D98-BC08-B42E5821053FQ33709363-8445C487-F265-4BE3-B7E6-F6BCF26608ECQ34207230-2D302E13-FA90-4B20-9B99-F4CEA3FDE969Q34221568-4AC0A2C2-709B-4FDF-9039-EF848FF27DC3Q35245061-4123834D-43F1-4B07-99D6-D04A5516796BQ35985440-240B1D52-2C30-44B7-B30B-6110CFF29614Q36048793-4445DE19-350A-4A82-9311-81BB3BC331AAQ36083409-05CC294D-12C5-4091-863E-A89A642FC18CQ36285939-F4657257-E98C-4057-ABCC-1D052677F30BQ36558056-D4ED262D-0F98-4257-B908-2BD03DE492A0Q36589067-1B6BF52E-3AA5-42C7-BE6A-91DDAFF73462Q36644102-D43AFE54-C5A8-4A51-A568-DAA946A2274FQ36833925-A1D137E2-5A8F-4D39-8468-867C7A3F3ABFQ36843205-AFE57B44-4CA6-4129-ADD7-C0652FEDDB81Q37067266-543F667A-3D84-4D1D-911D-5F6386DE5570Q37114759-E8032943-84DC-4CC3-A361-5EA35F7DF540Q37248918-14044DAF-F609-4170-980B-71EB6361050FQ37282107-6468F6ED-CB4D-408E-A98F-9E4D3AC3978DQ37697671-D2654C9A-34B8-485A-9704-B049B93200F2Q37731331-75C887A0-DB9A-4C6C-8205-A76E9F622718Q37895398-DF8E57F5-B592-48EB-BD0A-08A9935F1620Q37956509-15E34178-3278-4003-A1E6-7C19CE1D9FD2Q38089790-BCF0D1FD-F97F-494F-B7DC-76F1B5EDD077Q38827384-B8FD4417-9943-4A2A-9A69-7C014EC1E8FAQ38985991-97B5E639-E381-4A6B-AEFB-974565DE75F8Q40390176-9DAFC3A9-3860-455F-9AB1-03F1BC733857Q44346776-7C90C695-4511-4788-A8A9-43FEA854A2BAQ45842885-25EEC679-5AE5-4E67-ACCA-671B017E5D20Q47608243-E6E51BF0-4849-40C3-BDD8-28AFD5F9F5ADQ48078831-55DC4164-282E-4E91-9757-39B94B61F2C3Q48135779-13353A16-1FF0-4410-9379-E03E7E434036Q51139005-03F09585-9BF7-4047-BEA9-57B3D591DA5DQ53533652-6D0B7527-1930-4461-82BF-3DDD8B82D98A
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Bone cancer pain: from model to mechanism to therapy.
@ast
Bone cancer pain: from model to mechanism to therapy.
@en
type
label
Bone cancer pain: from model to mechanism to therapy.
@ast
Bone cancer pain: from model to mechanism to therapy.
@en
prefLabel
Bone cancer pain: from model to mechanism to therapy.
@ast
Bone cancer pain: from model to mechanism to therapy.
@en
P2093
P1476
Bone cancer pain: from model to mechanism to therapy.
@en
P2093
David B Mach
Molly A Sevcik
Nancy M Luger
Patrick W Mantyh
P304
P356
10.1016/J.JPAINSYMMAN.2005.01.008
P433
P577
2005-05-01T00:00:00Z